Portfolio map · Private equity · United States
Invus portfolio map
69 startups Invus has backed in rounds we track, since 2011, grouped by their main sector. Together they have raised $18B; Invus led at least one round in 1 of them. The biggest sector is Biotech, with 51 companies.
69startups backed
4sectors
$18Braised between them
Biotechbiggest sector
Biotech
51
Erasca- BBioNTech
Tyra Biosciences
Laronde
Arcus Biosciences
Encoded Therapeutics
Solid Biosciences
Morphic Therapeutic- CTCity Therapeutics
Leyden Labs
Matchpoint Therapeutics
Schrödinger
Osanni Bio
Repertoire Immune Medicines
Cartesian Therapeutics
Metacrine
Averna Therapeutics
Rani Therapeutics
Kaleido BioSciences
Hemab
KSQ Therapeutics
Lyndra Therapeutics
LEXEO Therapeutics
Septerna
+27 more
Funding by segment
- Biotech$9.1B51
- Healthtech$1.2B8
- Fintech$6.7B6
- Pharma$541M4
Where they are based
- United States55$10B
- France4$114M
- United Kingdom3$5.6B
- Germany1$687M
- Netherlands1$221M
- Denmark1$157M
- Ireland1$76M
United States
France
United Kingdom
Germany
Netherlands
Denmark
IrelandFounded
4Earlier
112
413
514
1015
516
517
518
419
720
321
322
123
124
25
26
11 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M3
- $10M to $50M6
- $50M to $250M46
- $250M to $1B12
- $1B and over1
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
57 of 69 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States55
- France4
- United Kingdom3
- Germany1
- Netherlands1
- Denmark1
- Ireland1
Startups by country, 7 countries in all.
Segment by segment
Biotech
51 startups · $9.1B raised
- ErascaErasca is a developer of oncology drugs intended to provide precision oncology options.United States$739M
- BBioNTechGermany$687M
- Tyra BiosciencesTyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.United States$600M
- LarondeLaronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.United States$440M
- Arcus BiosciencesArcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.United States$427M
- Encoded TherapeuticsEncoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.United States$379M
- Solid BiosciencesSolid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.United States$333M
- Morphic TherapeuticMorphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.United States$328M
Healthtech
8 startups · $1.2B raised
VeraDermicsVeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts.United States$534M
Precision NeurosciencePrecision Neuroscience is a neurotechnology startup based in New York City, founded in 2021.United States$352M
Neptune MedicalNeptune Medical is a medical device company that develops endoscopic and surgical devices.United States$97M
Tisento TherapeuticsTisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.United States$81M- ZZenflowUnited States$56M
Pi HealthPi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manageUnited States$40M
BRIUSBRIUS is a healthcare company that focuses in the orthodontics and medical device industry.United States$25M- CMCardioGard MedicalCardioGard develops a specially designed arterial cannula for the removal of gaseous material during heart bypass surgeries.-$781K
Fintech
6 startups · $6.7B raised
FinastraFinastra provides the broadest portfolio of financial services software.United Kingdom$5.3B- MLMission LaneUnited States$500M
RainRain is an operator and custodian of digital currency exchange intended to make digital transactions.United States$408M
Marlette FundingMarlette Funding is a financial tech company tasked to empower customers.United States$225M
AmountAmount is a digital technology company that accelerates digital transformation for financial institutions.United States$159M
Future FinanceIreland$76M
Pharma
4 startups · $541M raised
ORIC PharmaceuticalsORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.United States$248M
Flare TherapeuticsFlare Therapeutics is a clinical-stage biotechnology company based in Cambridge, MA, founded in 2021.United States$123M
Triana BiomedicinesTRIANA Biomedicines is a private biopharmaceutical company founded in 2019 and based in Lexington, Massachusetts.United States$120M
Foghorn TherapeuticsFoghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,United States$50M
How this map is made. Every startup here has raised money in a round we track that names Invus as an investor, the first in 2011. Each sits under its main sector, read from its rounds, and each sector shows its best-funded first; sectors with fewer than three companies are left off. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosPrivate equity · United StatesGaingels493 startups · 12 sectors · $40BPrivate equity · United StatesGoldman Sachs294 startups · 12 sectors · $163BPrivate equity · United StatesPioneer Fund289 startups · 12 sectors · $5.9BPrivate equity · United StatesRA Capital Management264 startups · 5 sectors · $48BPrivate equity · United StatesOrbiMed221 startups · 4 sectors · $34BPrivate equity · United StatesCormorant Asset Management123 startups · 3 sectors · $25B
Raising from investors like Invus?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.